|Description||(1R,2S)-VU0155041 is a partial mGluR4-positive allosteric modulator (EC50= 2.35 μM) that dependently attenuated hyperalgesia in neuropathic pain model rats.|
|Brife Description||A partial mGluR4 agonist (EC50= 2.35 μM)|
|Synonyms||(1R,2S)-2-[(3,5-dichlorophenyl)carbamoyl]cyclohexane-1-carboxylic acid; VU 0155041; VU-0155041; VU0155041|
|Solubility||DMSO: ≥ 59 mg/mL|
|Storage||Store in a cool and dry place (or refer to the Certificate of Analysis).|
|Boiling Point||540.2±50.0 ℃ at 760 Torr|
VU 1545 is a metabotropic glutamate receptor 5 (mGlu5) positive allosteric modulator (EC50 = 9.6 nM, Ki = 156 nM at rat mGlu5).
DL-AP3 has been found to be an inhibitor of mGluR as well as HPSP.
YM 202074 is a high affinity and selective metabotropic glutamate receptor type 1 (mGlu1) antagonist. YM 202074 binds to an allosteric site of the rat mGlu1 rec...
Z-Cyclopentyl-AP4 is a group III mGlu receptor agonist with higher potency at mGlu4 than mGlu8 (EC50 = 49 and 124 μM, respectively). Z-Cyclopentyl-AP4 selective...
UBP1112 is a selective group III mGlu receptor antagonist (apparent Kd = 5.1 and 488 μM for group III and group II mGlu receptors respectively; IC50 > 1 mM for ...
Desmethyl-YM 298198 is a derivative of YM 298198, a selective antagonist of mGlu1.
ADX-47273 is a drug used in scientific research which acts as a positive allosteric modulator selective for the metabotropic glutamate receptor subtype mGluR5.
(±)-trans-ACPD has been found to be a mGluR2 agonist.